Similar articles

• The commercial genetic testing landscape for Parkinson's disease.

  Cook L, Schulze J, Verbrugge J, Beck JC, Marder KS, Saunders-Pullman R, Klein C, Naito A, Alcalay RN; ClinGen Parkinson's Disease Gene Curation Expert Panel and the MDS Task Force for Recommendations for Genetic Testing in Parkinson's Disease; Clinical Genome Resource (ClinGen) Parkinson's Disease Gene Curation Expert Panel Authors; Movement Society Disorder (MDS) Task Force on Recommendations for Clinical Genetic Testing in Parkinson's Disease Authors. Cook L, et al. Parkinsonism Relat Disord. 2021 Nov;92:107-111. doi: 10.1016/j.parkreldis.2021.10.001. Epub 2021 Oct 19. Parkinsonism Relat Disord. 2021. PMID: 34696975 Free PMC article.
• The genetics of Parkinson disease: to test or not to test.

  Suchowersky O. Suchowersky O. Can J Neurol Sci. 2007 Aug;34(3):266-7. doi: 10.1017/s0317167100006661. Can J Neurol Sci. 2007. PMID: 17803021 No abstract available.
• LRRK2: both a cause and a risk factor for Parkinson disease?

  Foroud T. Foroud T. Neurology. 2005 Sep 13;65(5):664-5. doi: 10.1212/01.wnl.0000179342.58181.c9. Neurology. 2005. PMID: 16157895 No abstract available.
• Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes.

  Crosiers D, Theuns J, Cras P, Van Broeckhoven C. Crosiers D, et al. J Chem Neuroanat. 2011 Oct;42(2):131-41. doi: 10.1016/j.jchemneu.2011.07.003. Epub 2011 Jul 26. J Chem Neuroanat. 2011. PMID: 21810464 Review.
• [Genetic testing for Parkinson's disease: indication and practical implementation].

  Tönges L, Ip CW, Dresel C, Lingor P, Csoti I, Kohl Z, Winkler J, Klebe S. Tönges L, et al. Fortschr Neurol Psychiatr. 2020 Sep;88(9):601-608. doi: 10.1055/a-1155-6389. Epub 2020 Jun 28. Fortschr Neurol Psychiatr. 2020. PMID: 32594506 Review. German.